Literature DB >> 15978617

Crystal structure of the ENT domain of human EMSY.

Gayatri B Chavali1, Caroline M S Ekblad, Balaka P Basu, Nigel C Brissett, Dmitry Veprintsev, Luke Hughes-Davies, Tony Kouzarides, Laura S Itzhaki, Aidan J Doherty.   

Abstract

EMSY is a recently discovered gene encoding a BRCA2-associated protein and is amplified in some sporadic breast and ovarian cancers. The EMSY sequence contains no known domain except for a conserved approximately 100 residue segment at the N terminus. This so-called ENT domain is unique in the human genome, although multiple copies are found in Arabidopsis proteins containing members of the Royal family of chromatin remodelling domains. Here, we report the crystal structure of the ENT domain of EMSY, consisting of a unique arrangement of five alpha-helices that fold into a helical bundle arrangement. The fold shares regions of structural homology with the DNA-binding domain of homeodomain proteins. The ENT domain forms a homodimer via the anti-parallel packing of the extended N-terminal alpha-helix of each molecule. It is stabilized mainly by hydrophobic residues at the dimer interface and has a dissociation constant in the low micromolar range. The dimerisation of EMSY mediated by the ENT domain could provide flexibility for it to bind two or more different substrates simultaneously.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978617     DOI: 10.1016/j.jmb.2005.05.047

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

Review 1.  The function of EMSY in cancer development.

Authors:  Jing Hou; Ziliang Wang; Lina Yang; Xiaomao Guo; Gong Yang
Journal:  Tumour Biol       Date:  2014-03-09

2.  Binding of EMSY to HP1beta: implications for recruitment of HP1beta and BS69.

Authors:  Caroline M S Ekblad; Gayatri B Chavali; Balaka P Basu; Stefan M V Freund; Dmitry Veprintsev; Luke Hughes-Davies; Tony Kouzarides; Aidan J Doherty; Laura S Itzhaki
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

3.  Bromodomain factor 5 is an essential regulator of transcription in Leishmania.

Authors:  Nathaniel G Jones; Vincent Geoghegan; Gareth Moore; Juliana B T Carnielli; Katherine Newling; Félix Calderón; Raquel Gabarró; Julio Martín; Rab K Prinjha; Inmaculada Rioja; Anthony J Wilkinson; Jeremy C Mottram
Journal:  Nat Commun       Date:  2022-07-13       Impact factor: 17.694

4.  Amplification of EMSY gene in a subset of sporadic pancreatic adenocarcinomas.

Authors:  W Arnout van Hattem; Ralph Carvalho; Ang Li; G Johan A Offerhaus; Michael Goggins
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

5.  The basic helix loop helix domain of maize R links transcriptional regulation and histone modifications by recruitment of an EMSY-related factor.

Authors:  J Marcela Hernandez; Antje Feller; Kengo Morohashi; Kenneth Frame; Erich Grotewold
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-15       Impact factor: 11.205

6.  Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations.

Authors:  Konstantin J Dedes; Paul M Wilkerson; Daniel Wetterskog; Britta Weigelt; Alan Ashworth; Jorge S Reis-Filho
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

7.  Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.

Authors:  Kirsi M Määttä; Riikka Nurminen; Minna Kankuri-Tammilehto; Anne Kallioniemi; Satu-Leena Laasanen; Johanna Schleutker
Journal:  BMC Cancer       Date:  2017-07-24       Impact factor: 4.430

8.  The EMSY Gene Collaborates with CCND1 in Non-Small Cell Lung Carcinogenesis.

Authors:  Onur Baykara; Nejat Dalay; Burak Bakir; Pelin Bulut; Kamil Kaynak; Nur Buyru
Journal:  Int J Med Sci       Date:  2017-06-23       Impact factor: 3.738

9.  The EMSY threonine 207 phospho-site is required for EMSYdriven suppression of DNA damage repair.

Authors:  Petar Jelinic; Laura A Eccles; Jill Tseng; Paulina Cybulska; Monicka Wielgos; Simon N Powell; Douglas A Levine
Journal:  Oncotarget       Date:  2017-02-21

10.  The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.

Authors:  Emmanuelle Viré; Christina Curtis; Veronica Davalos; Anna Git; Samuel Robson; Alberto Villanueva; August Vidal; Isaia Barbieri; Samuel Aparicio; Manel Esteller; Carlos Caldas; Tony Kouzarides
Journal:  Mol Cell       Date:  2014-02-27       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.